Hot Products

Basic Information

Post buying leads

Suppliers

Cas Database

Name	(E,E)-Farnesol	EINECS	225-004-1
CAS No.	106-28-5	Density	0.875 g/cm³
PSA	20.23000	LogP	4.39790
Solubility	Miscible with alcohol. Immiscible with water.	Melting Point	61-63 °C
Formula	C₁₅H₂₆O	Boiling Point	283.4 °C at 760 mmHg
Molecular Weight	222.371	Flash Point	112.5 °C
Transport Information	N/A	Appearance	N/A
Safety	24/25	Risk Codes	43
Molecular Structure		Hazard Symbols	Xi
Synonyms	2,6,10-Dodecatrien-1-ol,3,7,11-trimethyl-(farnesol) (7CI);2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-,(E,E)- (8CI);(2E,6E)-Farnesol;(E)-b-Farnesol;2,6,10-Dodecatrien-1-ol,3,7,11-trimethyl-, (2E,6E)-;2,6-Di-trans-farnesol;2-trans,6-trans-Farnesol;3,7,11-Trimethyldodeca-2-trans,6-trans,10-trien-1-ol;Inhibitor A2;all-E-Farnesol;all-trans-Farnesol;trans,trans-Farnesol;trans-Farnesol;	Article Data	64

(E,E)-Farnesol Synthetic route

: 19954-66-6
ethyl farnesoate

: 106-28-5
Farnesol

Conditions

Conditions	Yield
With lithium aluminium tetrahydride In diethyl ether at 0 - 20℃; Inert atmosphere;	95%
With lithium aluminium tetrahydride In diethyl ether at 20℃;	90%
With lithium aluminium tetrahydride In diethyl ether	88%
Stage #1: ethyl farnesoate With aluminum (III) chloride; lithium aluminium tetrahydride In diethyl ether at -5℃; for 1h; Stage #2: With sodium hydroxide

: 372-97-4, 13058-04-3, 25744-33-6, 27248-37-9, 27248-38-0, 40716-68-5
farnesyl pyrophosphate

: 106-28-5
Farnesol

Conditions

Conditions	Yield
With water; alkaline phosphatase at 37℃; for 5h; Enzymatic reaction;
With calf intestine phosphatase; magnesium chloride In hexane at 30℃; for 2h; pH=7.5; Enzymatic reaction;
With calf intestinal phosphatase; water at 37℃; for 1h; pH=7.9; Enzymatic reaction;

: 6784-45-8, 67023-85-2, 72132-86-6, 67023-84-1
(2E,6E)-farnesyl chloride

: 106-28-5
Farnesol

Conditions

Conditions	Yield
With potassium hydroxide; sodium hydroxide In methanol for 24h; Reflux;	85%

: 40716-66-3
(E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol

A: 3790-71-4
(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

B: 106-28-5
Farnesol

Conditions

Conditions	Yield
O=W(OR)4-ligand at 180 - 200℃;
Stage #1: (E)-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol With vinyl acetate; Amano Lipase PS; C10H10NO6V In toluene at 50℃; for 168h; Enzymatic reaction; Stage #2: With potassium carbonate In methanol at 0℃; for 2h; Overall yield = 67.7 %Chromat.; Optical yield = 78.947 %de; diastereoselective reaction;

: 72019-02-4
(6E)-3,7,11-trimethyldodeca-2,6,10-trienal

A: 3790-71-4
(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

B: 106-28-5
Farnesol

Conditions

Conditions	Yield
With [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2; formic acid triethylamine complex; N-tosylethylenediamine In ethyl acetate at 20℃; for 20h; Inert atmosphere; Overall yield = 98 %;
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical In chlorobenzene at 130℃; for 72h; Reagent/catalyst;

: 226090-90-0
(6E)-farnesyl acetate

A: 3790-71-4
(2Z,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-ol

B: 106-28-5
Farnesol

Conditions

Conditions	Yield
With potassium carbonate In methanol at 0℃; for 2h; Overall yield = 86%; Overall yield = 1.45 mg;
With water; sodium hydroxide In methanol at 20℃; for 0.5h; Reagent/catalyst; Overall yield = 94 percent; Overall yield = 209 mg;

: 76386-25-9
trans,trans-farnesyl diphenylurethane

: 106-28-5
Farnesol

Conditions

Conditions	Yield
With potassium hydroxide In ethanol; water for 6h; Heating;	93%

: 97344-88-2
isopentenylmagnesium bromide

: 95763-58-9
3,7-dimethyl-8-<(tetrahydro-2H-pyran-2-yl)oxy>-2E,6E-octadien-1-ol

: 106-28-5
Farnesol

Conditions

Conditions	Yield
With copper(l) iodide In tetrahydrofuran for 12h;	54%

: 72019-02-4
(6E)-3,7,11-trimethyldodeca-2,6,10-trienal

: 106-28-5
Farnesol

Conditions

Conditions	Yield
With 2,2,6,6-Tetramethyl-1-piperidinyloxy free radical In chlorobenzene at 130℃; for 17.5h; Reagent/catalyst;

: 61890-77-5
(2E,6E)-1-(tert-butyldimethylsilyloxy)-3,7,1,1-trimethyldodeca-2,6,10-triene

: 106-28-5
Farnesol

Conditions

Conditions	Yield
With phosphomolybdic acid hydrate; silica gel In tetrahydrofuran at 20℃; for 0.25h;	97%

(E,E)-Farnesol Chemical Properties

The Molecular Structure of (E,E)-Farnesol (CAS NO.106-28-5):

IUPAC Name: 2,6,10-Dodecatrien-1-ol,3,7,11-trimethyl-, (2E,6E)-
Molecular Formula: C₁₅H₂₆O
Molecular Weight: 222.366340 g/mol
Index of Refraction: 1.485
Molar Refractivity: 72.77 cm³
Molar Volume: 253.8 cm³
Surface Tension: 30.3 dyne/cm
Density: 0.875 g/cm³
Flash Point: 112.5 °C
Enthalpy of Vaporization: 60.62 kJ/mol
Boiling Point: 283.4 °C at 760 mmHg
Vapour Pressure: 0.00037 mmHg at 25 °C
XLogP3-AA: 4.8
H-Bond Donor: 1
H-Bond Acceptor: 1
Rotatable Bond Count: 7
Exact Mass: 222.198365
MonoIsotopic Mass: 222.198365
Topological Polar Surface Area: 20.2
Heavy Atom Count: 16
Canonical SMILES: CC(=CCCC(=CCCC(=CCO)C)C)C
Isomeric SMILES: CC(=CCC/C(=C/CC/C(=C/CO)/C)/C)C
InChI: InChI=1S/C15H26O/c1-13(2)7-5-8-14(3)9-6-10-15(4)11-12-16/h7,9,11,16H,5-6,8,10,12H2,1-4H3/b14-9+,15-11+
InChIKey: CRDAMVZIKSXKFV-YFVJMOTDSA-N
EINECS: 225-004-1
Classification Code: TSCA Flag P [A commenced PMN (Premanufacture Notice) substance]

(E,E)-Farnesol Uses

(E,E)-Farnesol (CAS NO.106-28-5) can be widely used as perfuming agent in cosmetics. It can also be used as food flavor.

(E,E)-Farnesol Safety Profile

Safety Statements: 24/25
S24/25:Avoid contact with skin and eyes.
WGK Germany: 3
RTECS: JR4979000
F: 8

(E,E)-Farnesol Specification

(E,E)-Farnesol (CAS NO.106-28-5) is also named as 2,6-Di-trans-farnesol ; 2-trans,6-trans-Farnesol ; Inhibitor A2 ; all-trans-Farnesol ; trans-Farnesol ; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, (2E,6E)- ; 2,6,10-Dodecatrien-1-ol, 3,7,11-trimethyl-, (E,E)- . (E,E)-Farnesol (CAS NO.106-28-5) is colorless oily liquid.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 106-28-5